Pharmaceutical Evaluation of Levofloxacin Orally Disintegrating Tablet Formulation Using Low Frequency Raman Spectroscopy.
crystalline form
levofloxacin
low frequency Raman spectroscopy
orally disintegrating tablet
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
29 Jul 2023
29 Jul 2023
Historique:
received:
26
05
2023
revised:
14
07
2023
accepted:
27
07
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
We evaluated the pharmaceutical properties of levofloxacin (LV) in the form of an orally disintegrating tablet (LV
Identifiants
pubmed: 37631255
pii: pharmaceutics15082041
doi: 10.3390/pharmaceutics15082041
pmc: PMC10459943
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Appl Spectrosc. 2014;68(7):758-76
pubmed: 25014842
J Pharm Sci. 2007 May;96(5):990-5
pubmed: 17455356
Org Process Res Dev. 2013 Jul 19;17(7):976-980
pubmed: 27642248
Anal Chem. 2011 Aug 1;83(15):5972-8
pubmed: 21651233
Anal Chem. 2003 May 1;75(9):2140-6
pubmed: 12720353
Mol Pharm. 2017 Dec 4;14(12):4675-4684
pubmed: 29091447
Appl Spectrosc. 2009 Sep;63(9):979-91
pubmed: 19796479
Chem Pharm Bull (Tokyo). 2023;71(2):165-174
pubmed: 36724979